Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1052Neoplasms 886Prostatic Neoplasms 505Lung Neoplasms 422Colorectal Neoplasms 350Motor Activity 221Head and Neck Neoplasms 191Uterine Cervical Neoplasms 186Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 168Pancreatic Neoplasms 162Ovarian Neoplasms 139Colonic Neoplasms 138Carcinoma, Hepatocellular 134Anxiety Disorders 124Rectal Neoplasms 118Hematologic Neoplasms 114Multiple Myeloma 107Stomach Neoplasms 102Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 88Endometrial Neoplasms 85Lymphoma 83Disease 83Glioblastoma 79Gastrointestinal Neoplasms 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cancer Cachexia × 1 year × Clear all
NCT06476197 2025-07-17

Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy

S-Alpha Therapeutics, Inc.

Phase NA Completed
15 enrolled

Cancer Cachexia

NCT04153019 2025-06-12

PSYCHO-EDUCATIONAL AND REHABILITATIVE INTERVENTION FOR CANCER CACHEXIA (PRICC)

Azienda USL Reggio Emilia - IRCCS

Phase NA Completed
24 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡